Ten members of the committee reached their term limit in June. New confirmed members announced today are
Jitin Asnaani, Technical Expertise – Information Exchange
Josh Mandel, Provider Representative
Rich Elmore , Technical Vendor Representative
Angela Kennedy, Consumer/Patient Representative
Patty Sengstack, Provider Representative
Three more will be announced this Fall and the final two will be named in early 2016.
Jon White and Leslie Kelly Hall presented the Precision Medicine Task Force Recommendations
As you can see in the presentation, they divided up the required standards into green, yellow, red - ready for use, promising for use, and more work to be done. The committee offered a few recommendations i.e. move genomics standards from green to yellow, move consent standards from red to yellow, and clarify the interoperability standards advisory examples. The committee adopted the recommendations as revised. As mentioned above, the entire classification effort was guided by the Standards Maturity Model published in JAMIA
Next we heard from Steve Posnack , who presented the rubric/framework for sub regulatory standards guidance i.e. what standards are appropriate for what use case and what is their level of maturity? Specific scores (bubbles) are given to the adoption of every standard, making it very easy for developers to identify the right standard (or promising standard) to incorporate into their products.
Our October 6 meeting will be a joint meeting of the HIT Policy Committee and Standards Committee. I imagine we’ll discuss the recently released Federal Health IT Strategic Plan 2015-2020 . Still no word on the timing of Meaningful Use Stage 2 revisions and Meaningful Use Stage 3.